Hoffmann LS - Search Results

1

Nitric oxide-independent stimulation of soluble guanylate cyclase reduces organ damage in experimental low-renin and high-renin models.

Sharkovska Y, Kalk P, Lawrenz B, Godes M, Hoffmann LS, Wellkisch K, Geschka S, Relle K, Hocher B, Stasch JP. Sharkovska Y, et al. Among authors: hoffmann ls. J Hypertens. 2010 Aug;28(8):1666-75. doi: 10.1097/HJH.0b013e32833b558c. J Hypertens. 2010. PMID: 20613628

2

Chronic Activation of Heme Free Guanylate Cyclase Leads to Renal Protection in Dahl Salt-Sensitive Rats.

Hoffmann LS, Kretschmer A, Lawrenz B, Hocher B, Stasch JP. Hoffmann LS, et al. PLoS One. 2015 Dec 30;10(12):e0145048. doi: 10.1371/journal.pone.0145048. eCollection 2015. PLoS One. 2015. PMID: 26717150 Free PMC article.

3

Dimerization region of soluble guanylate cyclase characterized by bimolecular fluorescence complementation in vivo.

Rothkegel C, Schmidt PM, Atkins DJ, Hoffmann LS, Schmidt HH, Schröder H, Stasch JP. Rothkegel C, et al. Among authors: hoffmann ls. Mol Pharmacol. 2007 Nov;72(5):1181-90. doi: 10.1124/mol.107.036368. Epub 2007 Aug 22. Mol Pharmacol. 2007. PMID: 17715400

4

Fluorescence dequenching makes haem-free soluble guanylate cyclase detectable in living cells.

Hoffmann LS, Schmidt PM, Keim Y, Hoffmann C, Schmidt HH, Stasch JP. Hoffmann LS, et al. Among authors: hoffmann c. PLoS One. 2011;6(8):e23596. doi: 10.1371/journal.pone.0023596. Epub 2011 Aug 17. PLoS One. 2011. PMID: 21858179 Free PMC article.

5

Distinct molecular requirements for activation or stabilization of soluble guanylyl cyclase upon haem oxidation-induced degradation.

Hoffmann LS, Schmidt PM, Keim Y, Schaefer S, Schmidt HH, Stasch JP. Hoffmann LS, et al. Br J Pharmacol. 2009 Jul;157(5):781-95. doi: 10.1111/j.1476-5381.2009.00263.x. Epub 2009 May 18. Br J Pharmacol. 2009. PMID: 19466990 Free PMC article.

6

Stimulation of soluble guanylyl cyclase protects against obesity by recruiting brown adipose tissue.

Hoffmann LS, Etzrodt J, Willkomm L, Sanyal A, Scheja L, Fischer AWC, Stasch JP, Bloch W, Friebe A, Heeren J, Pfeifer A. Hoffmann LS, et al. Nat Commun. 2015 May 26;6:7235. doi: 10.1038/ncomms8235. Nat Commun. 2015. PMID: 26011238 Free PMC article.

7

cGMP: transition from bench to bedside: a report of the 6th International Conference on cGMP Generators, Effectors and Therapeutic Implications.

Hoffmann LS, Chen HH. Hoffmann LS, et al. Naunyn Schmiedebergs Arch Pharmacol. 2014 Aug;387(8):707-18. doi: 10.1007/s00210-014-0999-8. Epub 2014 Jun 15. Naunyn Schmiedebergs Arch Pharmacol. 2014. PMID: 24927824 Review.

8

Brown, beige, and white: the new color code of fat and its pharmacological implications.

Pfeifer A, Hoffmann LS. Pfeifer A, et al. Among authors: hoffmann ls. Annu Rev Pharmacol Toxicol. 2015;55:207-27. doi: 10.1146/annurev-pharmtox-010814-124346. Epub 2014 Aug 21. Annu Rev Pharmacol Toxicol. 2015. PMID: 25149919 Review.

9

cGMP and Brown Adipose Tissue.

Hoffmann LS, Larson CJ, Pfeifer A. Hoffmann LS, et al. Handb Exp Pharmacol. 2016;233:283-99. doi: 10.1007/164_2015_3. Handb Exp Pharmacol. 2016. PMID: 25903412 Review.

10

Regulation of metabolism by cGMP.

Pfeifer A, Kilić A, Hoffmann LS. Pfeifer A, et al. Among authors: hoffmann ls. Pharmacol Ther. 2013 Oct;140(1):81-91. doi: 10.1016/j.pharmthera.2013.06.001. Epub 2013 Jun 10. Pharmacol Ther. 2013. PMID: 23756133 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24 results

Search Page

Filters